All Pathways
CardiologyRisk Assessment

NSTEMI/ACS Risk Stratification (ESC 2023)

NSTEMI/ACS Risk Stratification (ESC 2023): NSTE-ACS Confirmed → Very High Risk Features? → Immediate ICA (<2h) → Antithrombotic Therapy → PCI/CABG as In...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    NSTE-ACS Confirmed

    Troponin positive, no ST elevation

    • Dynamic troponin rise/fall pattern
    • Ischemic symptoms
    • ECG: ST depression, T-wave changes, or normal
    1. Decision

      Very High Risk Features?

      Assess for immediate ICA criteria

      • Hemodynamic instability / cardiogenic shock
      • Recurrent/refractory chest pain
      • Life-threatening arrhythmias
      • Mechanical complications
      • Acute heart failure with ongoing ischemia
      • Recurrent dynamic ST/T changes

      If Yes:

      1. Action

        Immediate ICA (<2h)

        Very high risk - emergent angiography

        • Activate cath lab
        • Treat as STEMI-equivalent urgency
        • Hemodynamic support if needed
        1. Action

          Antithrombotic Therapy

          All NSTE-ACS patients

          • Aspirin loading 150-300mg
          • P2Y12 inhibitor (timing per strategy)
          • Anticoagulation: UFH or LMWH or Fondaparinux
          • Fondaparinux preferred if conservative
          1. Outcome

            PCI/CABG as Indicated

            Based on angiographic findings

          2. Outcome

            Optimal Medical Therapy

            If no significant CAD or not revascularizable

      If No:

      1. Decision

        High Risk Features?

        Assess for early invasive strategy

        • Confirmed NSTEMI (troponin rise/fall)
        • GRACE score >140
        • Dynamic ST/T-wave changes
        • Transient ST-elevation

        If Yes:

        1. Action

          Early Invasive (<24h)

          Class IIa recommendation (2023 downgrade)

          • ICA within 24 hours
          • Note: Downgraded from Class I in 2020
          • Based on TIMACS, VERDICT trials

        If No:

        1. Action

          Non-High Risk

          Selective invasive or non-invasive strategy

          • No high-risk features
          • Low GRACE score
          • Stable, no dynamic changes
          1. Action

            Non-Invasive Testing

            Stress testing or CT coronary angiography

            • Stress echo or stress CMR
            • CTCA for low-intermediate PTP
            • ICA if positive stress test
    2. Action

      Calculate GRACE Score

      Risk stratification tool

      • Age, Heart rate, Systolic BP
      • Creatinine, Killip class
      • Cardiac arrest at admission
      • ST deviation, Elevated markers
      • >140 = High risk, <140 = Lower risk

Guideline Source

2023 ESC Guidelines for the Management of Acute Coronary Syndromes

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • GRACE score calculator not integrated - use separate tool
  • Does not address specific antithrombotic dosing
  • Assumes confirmed NSTEMI diagnosis
  • Complex patients require cardiology consultation

Contraindicated Populations

pediatricpregnancy

Applicable Regions

EUUS

EU: ESC 2023 - ICA <24h now Class IIa (downgraded from Class I)

US: ACC/AHA similar approach with clinician judgment

Version 1Next review: 2027-10-01

Frequently Asked Questions

What is the NSTEMI/ACS Risk Stratification (ESC 2023)?

The NSTEMI/ACS Risk Stratification (ESC 2023) is a risk assessment clinical algorithm for Cardiology. It provides a structured decision tree to guide clinical decision-making, based on 2023 ESC Guidelines for the Management of Acute Coronary Syndromes.

What guideline is the NSTEMI/ACS Risk Stratification (ESC 2023) based on?

This algorithm is based on 2023 ESC Guidelines for the Management of Acute Coronary Syndromes (DOI: 10.1093/eurheartj/ehad191).

What are the limitations of the NSTEMI/ACS Risk Stratification (ESC 2023)?

Known limitations include: GRACE score calculator not integrated - use separate tool; Does not address specific antithrombotic dosing; Assumes confirmed NSTEMI diagnosis; Complex patients require cardiology consultation. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the NSTEMI/ACS Risk Stratification (ESC 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free